Advertisement

Vascular Muscle Membrane Properties in Hypertension

  • Kent Hermsmeyer
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 90)

Abstract

Although it would be ideal to present a discussion of how the coronary circulation is altered at the cell level in hypertension, there exist virtually no data comparing membrane properties of coronary vascular muscle cells from hypertensive and normotensive animals. However, the elevated peripheral resistance in hypertension is believed to be a predisposing influence to cardiac pathology. In this light, the present chapter is included to identify the changes in vascular muscle that result in increased peripheral resistance and so increase the workload of the heart.

Keywords

Total Peripheral Resistance Arterial Muscle Caudal Artery Vascular Muscle Trophic Influence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pfeffer MA, Frohlich ED, Pfeffer BA, Weiss AK: Pathophysiological implications of the increased cardiac output of young hypertensive rats. Circ Res (Suppl 1) 34, 35: 1235–1242, 1974.Google Scholar
  2. 2.
    Pfeffer MA, Fröhlich ED: Hemodynamic and myocardial function in young and old normotensive and spontaneously hypertensive rats. Circ Res (Suppl 1) 32, 33: 128–138, 1973. Google Scholar
  3. 3.
    Page E, Polimeni PI, Zak R, Earley J, Johnson M: Myofibrillar mass in rat and rabbit heart muscle: Correlation of microchemical and stereological measurements in normal and hypertrophic hearts. Circ Res 30: 430, 1972.PubMedGoogle Scholar
  4. 4.
    Lund DD, Tomanek RJ: Myocardial morphology of spontaneously hypertensive and aortic-constricted rats. Am J Anat 152: 141, 1978.PubMedCrossRefGoogle Scholar
  5. 5.
    Sen S, Tarazi RC, Bumpus FM: Cardiac hypertrophy and antihypertensive therapy. Cardiovasc Res 11: 427, 1977.PubMedCrossRefGoogle Scholar
  6. 6.
    Tomanek RJ: Selective effects of α-methyldopa on myocardial cell components independent of cell size in normotensive and genetically hypertensive rats. Hypertension 4: 499–506, 1982.PubMedGoogle Scholar
  7. 7.
    Tarazi RC,Levy MN: Cardiac responses to increased afterload. Hypertension (Suppl 2) 4: II8–II18, 1982Google Scholar
  8. 8.
    Schieken RM, Clark WR, Lauer RM: Left ventricular hypertrophy in children with blood pressures in the upper quintile of the distribution: The Muscatine study. Hypertension 3: 669, 1981.PubMedGoogle Scholar
  9. 9.
    Abboud FM: The sympathetic system in hypettension. Hypertension (Suppl 2)4:II208–II225, 1982.Google Scholar
  10. 10.
    Harder DR, Hermsmeyer K: Membrane mechanisms in arterial hypertension. Hypertension 5: 404–408, 1983.PubMedGoogle Scholar
  11. 11.
    Hermsmeyer K: Altered arterial muscle ion transport mechanism in the spontaneously hypertensive rat. J Cardiovasc Pharmacol 6: S10–S15, 1984.PubMedCrossRefGoogle Scholar
  12. 12.
    Jones AW: Vascular smooth muscle and alterations during hypertension. In: Bulbring E, Brading A, Jones A, Tomita T (eds) Smooth Muscle: An assessment of Current Knowledge. Univ of Texas Press Austin, TX: pp 397–429, 1981.Google Scholar
  13. 13.
    Mulvany MJ: Do resistance vessel abnormalities contribute to the elevated blood pressure of spontaneously-hypertensive rats? Blood Vessels 20: 1–22, 1983.PubMedGoogle Scholar
  14. 14.
    Haeuslet G, Finch L: Vascular reactivity to 5-hydro-xytryptamine and hypertension in the rat. Naunyn-Schmiedebergs Atch Pharmacol 272: 101, 1972.CrossRefGoogle Scholar
  15. 15.
    Jones AW: Altered ion transport in large and small arteries from spontaneously hypertensive rats and the influence of calcium. Circ Res. (Suppl 1) 34, 35: I117–I122, 1974.Google Scholar
  16. 16.
    Daniel EE, Kwan CY: Control of contraction of vascular muscle: Relation to hypertension. Trends Pharmacol Sei 2: 220–222, 1981.CrossRefGoogle Scholar
  17. 17.
    Hermsmeyer K Vascular muscle membrane cation mechanisms and total peripheral resistance.Hypertension (Suppl 1) 10: 20–22,1987Google Scholar
  18. 18.
    Folkow B, Hallback M, Lundgten Y, Weiss L: Structurally based increase of flow resistance in spontaneously hypertensive rats. Acta Physiol Scand 79: 373–378, 1970.PubMedCrossRefGoogle Scholar
  19. 19.
    Lais LT, Brody MJ: Vasoconstrictor hyperresponsiveness: An early pathogenic mechanism in the spontaneously hypertensive tat. Eut J Pharmacol 47: 177–189, 1978.CrossRefGoogle Scholar
  20. 20.
    Magliola L, McMahon EG, Jones AW: Alterations in active Na-K transport during hypertension. Am J Physiol 250: C540–C546, 1986.PubMedGoogle Scholar
  21. 21.
    Haddy FJ: Potassium effects on conttaction in artetial smooth muscle mediated by Na+, K+-ATPase. Fed Ptoc 42: 239–245, 1983.Google Scholar
  22. 22.
    Hermsmeyer K: Electrogenesis of increased norepinephrine sensitivity of artetial vascular muscle in hypertension. Circ Res 38: 362–367, 1976.PubMedGoogle Scholar
  23. 23.
    Ingram FD, Ingram MJ, Abel PW, Matsuki N, Tra-pani AJ, Hetmsmeyer K: Artetial muscle electrolytes and membtane potentials in Dahl hypettensive rats. Electron Microscopy 3: 88–89, 1980.Google Scholar
  24. 24.
    Hermsmeyer K: Electrogenic ion pumps and other determinants of membrane potential in vascular muscle (the 1982 Bowditch Lecture). Physiologist 25: 454–465, 1982.PubMedGoogle Scholar
  25. 25.
    Hermsmeyer K Walton S Specificity of altered electrogenesis of membrane potential in hypettension.Circ Res (Suppl I) 401153–1156, 1977.Google Scholar
  26. 26.
    Hatder DR, Contney SJ, Willems WJ, Stekiel WJ: Norepinephrine effect on in situ venous membrane potential in spontaneously hypettensive rats. Am J Physiol 240: H837–H842, 1981.Google Scholar
  27. 27.
    Hermsmeyer K, Abel PW, Trapani AJ: Norepinephrine sensitivity and membrane potentials of caudal arterial muscle in DOCA-salt, Dahl, and SHR hypertension in the rat. Hypertension (Suppl 2) 4 II49–II51, 1982.Google Scholar
  28. 28.
    Takeshita A, Mark AL: Neurogenic contribution to hindquarter vasoconstriction during high sodium intake in Dahl strain of genetically hypertensive rat, Circ Res 43: 186–191, 1978.Google Scholar
  29. 29.
    Abel PW, Hermsmeyer K: Sympathetic cross-inner-vation of SHR and genetic controls suggests a trophic influence on vascular muscle membranes. Circ Res 49: 1311–1318, 1981.PubMedGoogle Scholar
  30. 30.
    Brody MJ: New developments in our knowledge of blood pressure regulation. Fed Proc 40: 2257–2261, 1981.PubMedGoogle Scholar
  31. 31.
    Stekiel WJ, Contney SJ, Lombard JH, Harder DR: Response of venous membrane potentials to calcium blockade in spontaneous hypertension. Hypertension (Suppl I) 5: 164–169, 1983.Google Scholar
  32. 32.
    Davies PF, Oleson S-P, Clapham DE, Morrel EM, Schoen FJ: Endothelial communication. Hypertension 11: 563–572, 1988.PubMedGoogle Scholar
  33. 33.
    MacGregor GA, de Wardener HE: A circulating sodium transport inhibitor and essential hypertension. J Cardiovasc Pharmacol 6: S55–S60, 1984.PubMedCrossRefGoogle Scholar
  34. 34.
    Hamlyn JM, Ringel R, Schaeffer J, Levinson PD, Hamilton BP, Kowarski AA, Blaustein MP: A circulating inhibitor of (Na+ + K+) ATPase associated with essential hypertension. Nature 300: 650–652, 1982.PubMedCrossRefGoogle Scholar
  35. 35.
    Reuter H, Blaustein MP, Haeusler G: Na-Ca exchange and tension development in arterial smooth muscle. Phil Trans R Soc Lond B 265: 87–94, 1973.CrossRefGoogle Scholar
  36. 36.
    Blaustein MP: Sodium ions, calcium ions, blood pressure regulation, and hypertension: A reassessment and a hypothesis. Am J Physiol 232: C165–C173, 1977.PubMedGoogle Scholar
  37. 37.
    Blaustein MP: Sodium transport and hypertension: Where are we going? Hypertension 6: 445–453, 1984.PubMedGoogle Scholar
  38. 38.
    Lang S, Blaustein MP: The role of the sodium pump in the control of vascular tone in the rat. Circ Res 46:463–470, 1980.PubMedGoogle Scholar
  39. 39.
    Huot SJ, Pamnani MB, Clough DL, Haddy FJ: The role of sodium intake, the Na+-K+ pump and a ouabain-like humoral agent in the genesis of reduced renal mass hypertension. Am J Nephrol 3: 92–99, 1983.PubMedCrossRefGoogle Scholar
  40. 40.
    Hermsmeyer K: Sodium pump hyperpolarization-re-laxation in rat caudal artery. Fed Proc 42: 246–252, 1983.PubMedGoogle Scholar
  41. 41.
    Hermsmeyer K, Harder D: Membrane ATPase mechanism of the K+ return relaxation in stroke-prone SHR and WKY arterial muscles. Am J Physiol 250 (Cell Physiol) 19: C557–C562, 1986.Google Scholar
  42. 42.
    Mulvany MJ, Aalkjaer C, Petersen TT: Intracellular sodium, membrane potential, and contractility of rat mesenteric small arteries. Circ Res 54: 740–749, 1984.PubMedGoogle Scholar
  43. 43.
    van Breemen C, Leijten P, Yamamoto H, Aaronson P, Cauvin C Calcium activation of vascular smooth muscle. State of the art lecture. Hypertension (Suppl II): 8II89–II95, 1986.Google Scholar
  44. 44.
    Bean BP, Sturek M, Puga A, Hermsmeyer K: Calcium channels in vascular muscle cells isolated from rat mesenteric arteries: Modulation by dihydropyri-dine drugs. Circ Res 59: 229–235, 1986.PubMedGoogle Scholar
  45. 45.
    Sturek M, Hermsmeyer K: Calcium and sodium channels in spontaneously contracting vascular muscle cells. Science 233: 475–478, 1986.PubMedCrossRefGoogle Scholar
  46. 46.
    Rusch NJ, Hermsmeyer K: Calcium currents are altered in the vascular muscle cell membrane of spontaneously hypertensive rats. Circ Res, in press, 1988.Google Scholar
  47. 47.
    Erne P, Bolli P, Burgisser E, Buhler FR: Correlation of platelet calcium with blood pressure. N Engl J Med 310: 1084–1088, 1984.PubMedCrossRefGoogle Scholar
  48. 48.
    Bolli P, Erne P, Hulthen UL, Ritz R, Kiowski W, Ji BH, Buhler FR: Parallel reduction of calcium influx-dependent vasoconstriction and platelet-free calcium concentration with calcium entry and β-adrenoceptor blockade. J Cardiovasc Pharmacol 6: S996–S1001, 1984.PubMedCrossRefGoogle Scholar
  49. 49.
    McCarron DA: Low serving concentrations of ionized calcium in patients with hypertension. N Eng 1J Med 307: 226–228, 1982.CrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1989

Authors and Affiliations

  • Kent Hermsmeyer

There are no affiliations available

Personalised recommendations